Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.46
SNN's Cash to Debt is ranked higher than
51% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 4.48 vs. SNN: 0.46 )
SNN' s 10-Year Cash to Debt Range
Min: 0.07   Max: No Debt
Current: 0.46

Equity to Asset 0.71
SNN's Equity to Asset is ranked higher than
75% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. SNN: 0.71 )
SNN' s 10-Year Equity to Asset Range
Min: 0.26   Max: 0.74
Current: 0.71

0.26
0.74
Interest Coverage 81.00
SNN's Interest Coverage is ranked higher than
65% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: 117.58 vs. SNN: 81.00 )
SNN' s 10-Year Interest Coverage Range
Min: 7.79   Max: 94
Current: 81

7.79
94
F-Score: 5
Z-Score: 7.83
M-Score: -2.61
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 18.62
SNN's Operating margin (%) is ranked higher than
90% of the 371 Companies
in the Global Medical Devices industry.

( Industry Median: 6.50 vs. SNN: 18.62 )
SNN' s 10-Year Operating margin (%) Range
Min: 12.6   Max: 23.22
Current: 18.62

12.6
23.22
Net-margin (%) 12.78
SNN's Net-margin (%) is ranked higher than
88% of the 371 Companies
in the Global Medical Devices industry.

( Industry Median: 4.82 vs. SNN: 12.78 )
SNN' s 10-Year Net-margin (%) Range
Min: 8.9   Max: 26.81
Current: 12.78

8.9
26.81
ROE (%) 13.74
SNN's ROE (%) is ranked higher than
89% of the 368 Companies
in the Global Medical Devices industry.

( Industry Median: 5.93 vs. SNN: 13.74 )
SNN' s 10-Year ROE (%) Range
Min: 13.74   Max: 62.26
Current: 13.74

13.74
62.26
ROA (%) 9.55
SNN's ROA (%) is ranked higher than
91% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 3.43 vs. SNN: 9.55 )
SNN' s 10-Year ROA (%) Range
Min: 7.1   Max: 23.06
Current: 9.55

7.1
23.06
ROC (Joel Greenblatt) (%) 42.50
SNN's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 13.69 vs. SNN: 42.50 )
SNN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 25.6   Max: 49.01
Current: 42.5

25.6
49.01
Revenue Growth (%) 2.50
SNN's Revenue Growth (%) is ranked higher than
66% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. SNN: 2.50 )
SNN' s 10-Year Revenue Growth (%) Range
Min: -23.5   Max: 46.2
Current: 2.5

-23.5
46.2
EBITDA Growth (%) -1.30
SNN's EBITDA Growth (%) is ranked higher than
77% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: -3.60 vs. SNN: -1.30 )
SNN' s 10-Year EBITDA Growth (%) Range
Min: -15   Max: 42.9
Current: -1.3

-15
42.9
EPS Growth (%) -3.90
SNN's EPS Growth (%) is ranked higher than
71% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: -1.70 vs. SNN: -3.90 )
SNN' s 10-Year EPS Growth (%) Range
Min: -27.8   Max: 66.1
Current: -3.9

-27.8
66.1
» SNN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

SNN Guru Trades in Q2 2013

David Dreman 99,821 sh (+12.73%)
Ken Fisher 1,049,613 sh (+0.69%)
John Hussman 19,500 sh (unchged)
Jim Simons 51,001 sh (-29.94%)
Pioneer Investments 38,402 sh (-57.05%)
» More
Q3 2013

SNN Guru Trades in Q3 2013

Jim Simons 104,200 sh (+104.31%)
David Dreman 106,371 sh (+6.56%)
Pioneer Investments 38,402 sh (unchged)
John Hussman 19,500 sh (unchged)
Ken Fisher 1,048,381 sh (-0.12%)
» More
Q4 2013

SNN Guru Trades in Q4 2013

Ken Fisher 1,055,926 sh (+0.72%)
John Hussman 19,500 sh (unchged)
Pioneer Investments 38,402 sh (unchged)
Jim Simons 80,600 sh (-22.65%)
David Dreman 66,654 sh (-37.34%)
» More
Q1 2014

SNN Guru Trades in Q1 2014

David Dreman 78,118 sh (+17.2%)
Jim Simons 84,200 sh (+4.47%)
John Hussman 19,500 sh (unchged)
Pioneer Investments 38,402 sh (unchged)
Ken Fisher 994,111 sh (-5.85%)
» More
» Details

Insider Trades

Latest Guru Trades with SNN

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Dreman 2013-12-31 Reduce -37.34%0.22%$60.05 - $71.85 $ 90.3237%66654
John Hussman 2012-12-31 Add 56%0.01%$51.03 - $55.66 $ 90.3270%19500
David Dreman 2011-06-30 Add 43.79%0.02%$51.11 - $58.18 $ 90.3264%60856
John Hussman 2011-06-30 Add 83.33%$51.11 - $58.18 $ 90.3264%11000
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 29.00
SNN's P/E(ttm) is ranked higher than
83% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 67.30 vs. SNN: 29.00 )
SNN' s 10-Year P/E(ttm) Range
Min: 11.15   Max: 40.82
Current: 29

11.15
40.82
P/B 3.80
SNN's P/B is ranked higher than
67% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. SNN: 3.80 )
SNN' s 10-Year P/B Range
Min: 2.28   Max: 8.45
Current: 3.8

2.28
8.45
P/S 3.75
SNN's P/S is ranked higher than
65% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 3.28 vs. SNN: 3.75 )
SNN' s 10-Year P/S Range
Min: 1.47   Max: 5.09
Current: 3.75

1.47
5.09
PFCF 39.00
SNN's PFCF is ranked higher than
83% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 2429.50 vs. SNN: 39.00 )
SNN' s 10-Year PFCF Range
Min: 12.7   Max: 160
Current: 39

12.7
160
EV-to-EBIT 19.30
SNN's EV-to-EBIT is ranked higher than
85% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 44.62 vs. SNN: 19.30 )
SNN' s 10-Year EV-to-EBIT Range
Min: 8.6   Max: 129.6
Current: 19.3

8.6
129.6
PEG 7.20
SNN's PEG is ranked higher than
87% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SNN: 7.20 )
SNN' s 10-Year PEG Range
Min: 0.44   Max: 7.2
Current: 7.2

0.44
7.2
Shiller P/E 27.00
SNN's Shiller P/E is ranked higher than
92% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SNN: 27.00 )
SNN' s 10-Year Shiller P/E Range
Min: 14.24   Max: 37.21
Current: 27

14.24
37.21
Current Ratio 2.25
SNN's Current Ratio is ranked higher than
63% of the 379 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. SNN: 2.25 )
SNN' s 10-Year Current Ratio Range
Min: 0.8   Max: 2.75
Current: 2.25

0.8
2.75
Quick Ratio 1.24
SNN's Quick Ratio is ranked higher than
56% of the 379 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. SNN: 1.24 )
SNN' s 10-Year Quick Ratio Range
Min: 0.45   Max: 1.62
Current: 1.24

0.45
1.62

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.48
SNN's Dividend Yield is ranked higher than
65% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 1.26 vs. SNN: 1.48 )
SNN' s 10-Year Dividend Yield Range
Min: 0.73   Max: 2.29
Current: 1.48

0.73
2.29
Dividend Payout 0.42
SNN's Dividend Payout is ranked higher than
57% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SNN: 0.42 )
SNN' s 10-Year Dividend Payout Range
Min: 0.28   Max: 4.31
Current: 0.42

0.28
4.31
Dividend growth (3y) 21.90
SNN's Dividend growth (3y) is ranked higher than
90% of the 89 Companies
in the Global Medical Devices industry.

( Industry Median: 7.60 vs. SNN: 21.90 )
SNN' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 52.8
Current: 21.9

0
52.8
Yield on cost (5-Year) 3.42
SNN's Yield on cost (5-Year) is ranked higher than
88% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 1.30 vs. SNN: 3.42 )
SNN' s 10-Year Yield on cost (5-Year) Range
Min: 1.66   Max: 5.22
Current: 3.42

1.66
5.22
Share Buyback Rate -0.60
SNN's Share Buyback Rate is ranked higher than
80% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: -0.90 vs. SNN: -0.60 )
SNN' s 10-Year Share Buyback Rate Range
Min: 23.5   Max: -26.3
Current: -0.6

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 8.50
SNN's Price/Tangible Book is ranked higher than
62% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 6.18 vs. SNN: 8.50 )
SNN' s 10-Year Price/Tangible Book Range
Min: 4.37   Max: 178.35
Current: 8.5

4.37
178.35
Price/DCF (Projected) 2.00
SNN's Price/DCF (Projected) is ranked higher than
89% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. SNN: 2.00 )
SNN' s 10-Year Price/DCF (Projected) Range
Min: 1.1   Max: 3.84
Current: 2

1.1
3.84
Price/Median PS Value 1.30
SNN's Price/Median PS Value is ranked higher than
66% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 1.18 vs. SNN: 1.30 )
SNN' s 10-Year Price/Median PS Value Range
Min: 0.53   Max: 1.87
Current: 1.3

0.53
1.87
Price/Graham Number 3.30
SNN's Price/Graham Number is ranked higher than
78% of the 411 Companies
in the Global Medical Devices industry.

( Industry Median: 8.75 vs. SNN: 3.30 )
SNN' s 10-Year Price/Graham Number Range
Min: 1.56   Max: 17.74
Current: 3.3

1.56
17.74
Earnings Yield (Greenblatt) 5.10
SNN's Earnings Yield (Greenblatt) is ranked higher than
75% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 4.90 vs. SNN: 5.10 )
SNN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.8   Max: 11.6
Current: 5.1

0.8
11.6
Forward Rate of Return (Yacktman) 6.33
SNN's Forward Rate of Return (Yacktman) is ranked higher than
84% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. SNN: 6.33 )
SNN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 6.6   Max: 53.5
Current: 6.33

6.6
53.5

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:SN..UK, NPW1.Germany, NPWA.Germany, SNNUF.USA
Smith & Nephew PLC, together with its subsidiaries, is engaged in developing, manufacturing, marketing and selling medical devices in the sectors of Orthopaedics, Endoscopy and Advanced Wound Management. Its three operating segments are Orthopaedics, Endoscopy and Advanced Wound Management. Orthopaedic comprises reconstruction, trauma and clinical therapies products. Orthopaedic reconstruction implants include hip, knee and shoulder joints as well as ancillary products such as bone cement. Orthopaedic trauma fixation products consist of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilisation of severe fractures and deformity correction procedures. Endoscopy business develops and commercialises endoscopic (minimally invasive surgery) techniques, educational programmes and value-added services for surgeons to treat and repair soft tissue and articulating joints. The business focuses on the arthroscopy sector of the endoscopy market. Advanced Wound Management business offers a range of products from initial wound bed preparation through to full wound closure. These products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers. There are also products for the treatment of wounds such as burns and invasive surgery that impact the wider population. The group operates in the Europe, United States, Africa, Asia, Australasia and other America.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide